Co-Diagnostics, Inc. (CODX)
NASDAQ: CODX · Real-Time Price · USD
6.07
-2.46 (-28.84%)
Jun 1, 2026, 1:31 PM EDT - Market open
Co-Diagnostics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 0.72 | 0.62 | 3.92 | 6.81 | 34.22 | 97.89 | |
Revenue Growth (YoY) | -79.47% | -84.10% | -42.53% | -80.09% | -65.04% | 31.30% |
Cost of Revenue | 0.39 | 0.22 | 1 | 4.18 | 5.48 | 11.57 |
Gross Profit | 0.32 | 0.4 | 2.92 | 2.63 | 28.74 | 86.31 |
Selling, General & Admin | 10.98 | 11.44 | 20.64 | 21.14 | 21.61 | 24.95 |
Depreciation & Amortization Expenses | 1.08 | 1.11 | 1.38 | 1.23 | 1.28 | 0.34 |
Research & Development | 20.2 | 19.14 | 20.98 | 22.96 | 17.44 | 14.96 |
Other Operating Expenses | - | 18.88 | - | - | 15.39 | - |
Total Operating Expenses | 32.26 | 50.57 | 43 | 45.33 | 55.72 | 40.25 |
Operating Income | -50.82 | -50.17 | -40.08 | -42.71 | -26.98 | 46.07 |
Interest Income | 0.67 | 0.98 | 1.96 | 3.4 | 0.7 | 0.05 |
Other Non-Operating Income (Expense) | 0.02 | 0.68 | 0.54 | 1.19 | 7.43 | -0.47 |
Total Non-Operating Income (Expense) | 0.69 | 1.65 | 2.5 | 4.6 | 8.13 | -0.43 |
Pretax Income | -50.13 | -48.51 | -37.58 | -38.11 | -18.85 | 45.64 |
Provision for Income Taxes | -1.63 | -1.62 | 0.06 | -2.78 | -4.61 | 8.98 |
Net Income | -48.5 | -46.9 | -37.64 | -35.33 | -14.24 | 36.66 |
Net Income to Common | -48.5 | -46.9 | -37.64 | -35.33 | -14.24 | 36.66 |
Net Income Growth | - | - | - | - | - | -13.70% |
Shares Outstanding (Basic) | 2 | 1 | 1 | 1 | 1 | 1 |
Shares Outstanding (Diluted) | 2 | 1 | 1 | 1 | 1 | 1 |
Shares Change (YoY) | 57.93% | 31.55% | 3.37% | -6.77% | 5.27% | 6.80% |
EPS (Basic) | -32.41 | -35.25 | -37.22 | -36.00 | -13.50 | 38.10 |
EPS (Diluted) | -32.41 | -35.25 | -37.22 | -36.00 | -13.50 | 36.90 |
EPS Growth | - | - | - | - | - | -19.08% |
Shares Outstanding | 3.6 | 2.1 | 1.1 | 0.98 | 1.03 | 1.13 |
Free Cash Flow | -28.99 | -29.84 | -29.9 | -23.45 | 5.14 | 40.41 |
Free Cash Flow Growth | - | - | - | - | -87.28% | 47.54% |
Free Cash Flow Per Share | -17.83 | -22.43 | -29.57 | -23.97 | 4.90 | 40.54 |
Gross Margin | 45.06% | 64.28% | 74.48% | 38.57% | 83.98% | 88.17% |
Operating Margin | -7076.61% | -8058.83% | -1023.75% | -626.92% | -78.85% | 47.06% |
Profit Margin | -6753.69% | -7533.62% | -961.37% | -518.68% | -41.61% | 37.45% |
FCF Margin | -4036.41% | -4793.17% | -763.79% | -344.20% | 15.02% | 41.28% |
EBITDA | -49.74 | -49.06 | -38.7 | -41.48 | -25.7 | 46.4 |
EBITDA Margin | -6925.98% | -7881.03% | -988.57% | -608.86% | -75.10% | 47.40% |
EBIT | -50.82 | -50.17 | -40.08 | -42.71 | -26.98 | 46.07 |
EBIT Margin | -7076.61% | -8058.83% | -1023.75% | -626.92% | -78.85% | 47.06% |
Effective Tax Rate | 3.25% | 3.33% | -0.15% | 7.29% | 24.45% | 19.67% |